OneMedNet Welcomes Our Latest Subscriber mlHealth360

Rhea-AI Summary

OneMedNet (Nasdaq:ONMD) announced on October 20, 2025 that mlHealth360 has signed a multi-year subscription to OneMedNet’s iRWD™ platform for regulatory-grade, de-identified imaging and clinical data.

The subscription gives mlHealth360 ongoing access to curated X-ray and CT datasets sourced from 1,750+ healthcare provider sites and 131 million+ clinical studies, supporting AI model development, validation, and deployment. OneMedNet said the deal advances its subscription-based strategy and helps scale annual recurring revenue by expanding its customer base of AI and analytics firms.

Positive

• Multi-year subscription signed with mlHealth360
• Access to data from 1,750+ provider sites
• Access to 131M+ clinical studies for model development
• Deal supports subscription/ARR scaling for OneMedNet

Negative

• None.

Insights

Commercial Data Partnerships Analyst

Multi-year subscription from mlHealth360 strengthens OneMedNet's recurring-revenue model and expands imaging data demand.

OneMedNet secured a multi-year subscription from mlHealth360 for continuous access to the iRWD™ platform, providing de-identified X‑Ray and CT imaging and clinical data drawn from over 1,750 provider sites and 131 million+ clinical studies, per the release dated October 20, 2025. The arrangement explicitly targets AI model development, validation, and deployment and is described as part of OneMedNet’s subscription-based strategy designed to build annual recurring revenue.

The business mechanism here is straightforward: a multi-year subscription supplies predictable, ongoing data access to a client that uses imaging for AI, which supports revenue visibility and potential scaling of the subscription base. Dependencies and risks remain tied to the contract term, continued data quality and compliance, and customer retention; those elements determine how durable the cited recurring revenue will be. Concrete items to watch over a medium-term horizon include contract length and renewal terms, any disclosed revenue contribution from this customer, and whether additional similar subscriptions are announced in the next 12–24 months.

MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today that mlHealth360, a healthcare AI and analytics innovator, has chosen OneMedNet as its Real-World Data provider – marking another key milestone in the expansion of OneMedNet’s subscription-based business model.

Under the new multi-year agreement, mlHealth360 will subscribe to OneMedNet’s iRWD™ platform, providing continuous access to regulatory-grade, de-identified imaging and clinical data for AI model development, validation, and deployment. The subscription provides mlHealth360 with ongoing access to curated, X-Ray and CT datasets sourced from over 1,750 healthcare provider sites and 131 million+ clinical studies across multiple therapeutic areas.

The addition of mlHealth360 further strengthens our growing base of subscription customers,” said Aaron Green, President and CEO of OneMedNet. “Their decision to choose OneMedNet reinforces the trust and confidence organizations place in our ability to deliver multimodal, LIVE Real-World Data that fuels healthcare AI innovation. Our subscription business continues to scale through high-value relationships that build annual recurring revenue and drive long-term growth.”

“We partnered with OneMedNet to strengthen mlHealth360’s access to high-quality medical imaging data, which is key to advancing patient care,” said Kumar Surender Sinwar, CEO of mlHealth360. “Our early work together on Intracranial CT Head datasets produced outstanding results, and that success encouraged us to expand into new areas, including Xray and CT imaging. OneMedNet’s reliable and compliant Real-World Data helps us accelerate our AI model development and broaden our reach into critical healthcare segments where better access and faster decisions can save lives.”

The collaboration underscores OneMedNet’s strategy to expand its subscription-based data delivery model through partnerships with leading AI and analytics companies. It highlights the growing market demand for high-quality, multimodal Real-World Data (RWD) — including imaging, EHR, and outcomes data — that supports model training and regulatory-grade validation.

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

About mlHealth360

mlHealth360 is a healthcare AI and analytics company dedicated to transforming the future of medical imaging through secure, HIPAA-compliant, cloud-native solutions. Our advanced platform acts as a force multiplier for radiologists, delivering intelligent case triage, anomaly detection, and automated report generation—reducing diagnostic turnaround times and enhancing clinical decision-making. Designed for seamless integration with existing hospital systems, mlHealth360 offers scalable deployment across both cloud and on-premises environments.

With a growing network of healthcare partners across North America and Asia, mlHealth360 is driven by its core philosophy of Infinite Insight—turning complex medical data into actionable intelligence that empowers clinicians and improves patient outcomes.

Learn more at www.mlhealth360.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations..

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What did OneMedNet announce on October 20, 2025 regarding mlHealth360 (ONMD)?

OneMedNet announced a multi-year subscription with mlHealth360 for ongoing access to its iRWD™ platform.

What data will mlHealth360 receive from OneMedNet under the ONMD agreement?

mlHealth360 will receive regulatory-grade, de-identified X-ray and CT datasets plus clinical data from OneMedNet's platform.

How large is OneMedNet's dataset available to mlHealth360 (ONMD)?

The subscription provides access to data sourced from 1,750+ provider sites and over 131 million clinical studies.

How does the mlHealth360 deal affect OneMedNet's business model (ONMD)?

The company says the agreement supports its subscription-based model and helps scale annual recurring revenue through repeat customer relationships.

Will the OneMedNet and mlHealth360 partnership support AI model validation for ONMD customers?

Yes; the deal provides continuous access to regulatory-grade, de-identified imaging and clinical data intended for AI model development, validation, and deployment.

Which imaging modalities are included in the OneMedNet subscription to mlHealth360 (ONMD)?

The subscription specifically includes curated X-ray and CT imaging datasets across multiple therapeutic areas.